Accuracy of NHS Home Pulse Oximeters Across Skin Tones: A Diagnostic Study
January 18, 2026
Brand Name :
Kimmtrak
Synonyms :
tebentafusp-tebn
Class :
ImmTACs (Immune-mobilising monoclonal TCRs against cancer)
Dosage forms & Strengths:
Adult:
Injectable solution
100 mcg/0.5ml
20 mcg intravenously on day 1
30 mcg intravenously on day 8
68 mcg intravenously from the next week until toxicity is reduced
Safety and efficacy are not seen in pediatrics
>10%:
Rash
Pyrexia
Pruritus
Glucose increased
Fatigue
AST increased
ALT increased
Hemoglobin decreased
Phosphate decreased
Nausea
Chills
Albumin decreased
Abdominal pain
Calcium decreased
Edema
Hypotension
Lipase increased
Magnesium decreased
Alkaline phosphatase increased
Dry skin
Headache
Vomiting
Sodium decreased
Potassium increased
Skin hypopigmentation
Bilirubin increased
Diarrhea
Erythema
Amylase increased
Arthralgia
Hair color changes
Glucose decreased
Potassium decreased
Platelet count decreased
Neutrophil count decreased
Calcium increased
1-10%:
Pruritus
Bilirubin increased
Amylase increased
Pyrexia
Hypotension
Glucose increased
Abdominal pain
Sodium decreased
Alkaline phosphatase increased
Albumin decreased
Nausea
Neutrophil count decreased
Potassium increased
Calcium decreased
Diarrhea
Vomiting
<1%:
CRS
Arthralgia
Potassium decreased
Hemoglobin decreased
Chills
Headache
Tebentafusp is contraindicated in patients hypersensitive to the active ingredient.
Pregnancy consideration:
No data is available regarding the use of the drug in pregnant females.
Breastfeeding warnings:
No data is available regarding the excretion of the drug in breast milk.
Pregnancy category:
Patient information leaflet
Generic Name: tebentafusp
Pronounced: teb-en-tah-fusp
Why do we use tebentafusp?
Tebentafusp belongs to ImmTACs. It is used to treat uveal melanoma.